We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
CES2
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • CES2
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

CES2 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 368.33
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 266.2
Number of samples 362
Samples
Sample Description pTPM
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 1607.8
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 1216.1
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 1076.5
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 1035.9
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 1006.1
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 993.0
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 987.2
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 971.7
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 874.8
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 847.1
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 820.8
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 818.6
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 813.1
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 811.7
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 772.6
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 769.6
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 764.2
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 722.1
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 721.9
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 669.5
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 659.1
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 658.0
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 657.7
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 651.3
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 649.6
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 645.2
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 640.8
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 638.4
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 638.0
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 634.5
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 630.7
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 623.6
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 620.9
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 616.0
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 612.0
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 581.2
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 578.8
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 572.9
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 564.4
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 562.4
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 557.6
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 549.2
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 545.9
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 534.7
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 529.4
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 520.5
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 518.0
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 510.2
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 503.0
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 500.4
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 494.4
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 491.7
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 488.7
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 488.7
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 483.9
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 481.7
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 481.6
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 480.4
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 474.4
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 466.6
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 465.4
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 460.1
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 450.9
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 442.1
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 438.9
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 432.4
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 423.5
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 420.1
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 412.7
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 407.9
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 405.2
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 402.2
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 399.3
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 398.4
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 398.4
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 397.3
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 395.3
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 394.8
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 394.3
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 394.2
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 392.0
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 388.6
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 386.6
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 384.3
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 378.8
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 377.4
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 376.8
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 369.8
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 368.4
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 368.2
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 366.4
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 363.7
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 361.7
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 357.0
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 356.5
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 354.3
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 348.6
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 346.8
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 344.6
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 344.5
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 344.1
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 343.9
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 338.4
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 338.2
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 336.7
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 336.0
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 335.6
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 330.9
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 330.9
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 328.3
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 322.9
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 322.7
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 322.6
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 321.7
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 320.5
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 318.1
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 315.2
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 313.8
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 311.7
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 311.2
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 309.5
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 309.3
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 309.0
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 304.8
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 292.7
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 290.6
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 283.0
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 283.0
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 280.3
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 275.7
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 275.6
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 275.4
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 274.8
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 273.9
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 273.3
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 273.2
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 273.1
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 272.6
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 272.1
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 271.9
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 268.3
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 267.1
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 263.9
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 258.8
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 258.7
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 258.1
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 257.5
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 257.4
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 257.4
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 257.1
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 256.6
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 255.2
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 254.2
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 253.1
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 249.4
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 249.0
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 247.3
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 246.1
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 245.3
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 244.9
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 242.9
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 242.6
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 240.3
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 240.2
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 235.2
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 234.8
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 232.6
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 227.5
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 225.4
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 224.3
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 223.7
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 217.3
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 216.7
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 216.5
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 215.8
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 212.6
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 210.4
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 204.7
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 204.3
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 202.8
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 201.0
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 200.5
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 200.2
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 199.5
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 195.3
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 194.4
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 194.3
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 194.2
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 193.7
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 193.5
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 193.2
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 192.9
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 191.6
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 190.7
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 189.4
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 189.3
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 187.6
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 186.1
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 184.5
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 183.4
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 182.0
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 181.7
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 180.5
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 179.5
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 178.7
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 178.5
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 177.6
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 176.2
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 173.8
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 173.5
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 169.9
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 168.1
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 167.6
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 166.5
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 164.8
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 160.4
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 158.5
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 157.7
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 156.5
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 156.3
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 155.6
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 154.8
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 152.0
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 150.4
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 150.3
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 150.1
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 149.1
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 148.2
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 145.2
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 145.1
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 145.0
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 144.7
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 144.6
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 144.6
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 142.3
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 137.3
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 136.3
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 135.2
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 133.4
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 132.2
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 131.8
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 131.7
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 131.7
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 131.4
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 131.0
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 129.8
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 128.4
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 128.4
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 128.2
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 126.5
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 126.5
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 124.1
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 123.6
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 123.3
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 123.1
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 122.9
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 121.0
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 119.6
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 118.8
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 117.6
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 115.0
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 114.3
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 113.7
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 110.7
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 108.3
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 106.4
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 106.0
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 104.5
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 102.6
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 102.0
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 101.6
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 100.9
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 100.7
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 97.5
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 96.6
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 95.1
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 94.9
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 94.0
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 92.9
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 89.5
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 88.2
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 87.7
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 87.7
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 85.2
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 83.2
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 82.8
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 81.4
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 78.4
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 77.6
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 77.3
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 76.8
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 74.3
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 73.5
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 72.9
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 70.6
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 68.1
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 63.0
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 62.1
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 62.0
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 61.0
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 59.6
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 58.8
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 57.8
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 57.2
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 56.2
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 56.1
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 51.8
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 50.0
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 49.0
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 48.3
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 48.2
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 48.0
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 47.0
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 45.5
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 43.4
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 42.5
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 41.8
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 39.5
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 37.3
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 36.8
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 36.1
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 35.9
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 35.3
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 34.6
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 32.6
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 31.6
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 31.5
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 31.0
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 30.9
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 29.8
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 29.4
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 28.6
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 27.0
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 25.6
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 24.2
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 23.9
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 22.6
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 21.9
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 21.7
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 21.6
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 21.3
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 20.0
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 19.9
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 18.4
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 18.0
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 16.7
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 16.2
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 15.8
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 15.6
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 13.7
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 13.3
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 12.8
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 11.3
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 11.1
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 10.8
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 10.0
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 9.6
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 9.1
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 9.0
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 8.7
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 7.2
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 5.9
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

CES2 is potential prognostic, high expression is favorable in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 146.02
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 226.7
Number of samples 231
Samples
Sample Description pTPM
DO50783 62 years, male, NA, stage:3, alive, 480 days 1336.1
DO48746 76 years, male, NA, stage:3, alive, 570 days 1141.2
DO48677 58 years, male, NA, stage:3, alive, 1140 days 868.6
DO50811 62 years, male, NA, stage:1, alive, 450 days 850.1
DO50839 47 years, female, NA, stage:3, alive, 330 days 840.0
DO23539 77 years, male, NA, stage:1, alive, 1110 days 783.3
DO48695 77 years, male, NA, stage:2, alive, 720 days 746.6
DO50807 67 years, male, NA, stage:1, alive, 540 days 720.0
DO23512 60 years, male, NA, stage:1, alive, 1260 days 716.5
DO23543 63 years, male, NA, stage:2, alive, 1020 days 640.5
DO50804 81 years, male, NA, stage:2, alive, 720 days 637.4
DO45193 68 years, female, NA, stage:4, dead, 120 days 629.0
DO23534 60 years, male, NA, stage:2, alive, 840 days 626.6
DO45097 69 years, male, NA, stage:3, alive, 1620 days 590.6
DO45299 70 years, female, NA, stage:1, alive, 1440 days 556.0
DO23513 76 years, male, NA, stage:3, alive, 1200 days 542.9
DO45094 76 years, male, NA, stage:3, alive, 1650 days 506.7
DO23548 78 years, female, NA, stage:1, alive, 840 days 496.7
DO45129 61 years, male, NA, stage:3, alive, 1470 days 492.0
DO50817 75 years, male, NA, stage:2, alive, 390 days 483.5
DO23527 72 years, male, NA, stage:1, alive, 1050 days 480.6
DO50808 68 years, male, NA, stage:2, alive, 570 days 466.0
DO45111 74 years, male, NA, stage:2, alive, 1590 days 463.5
DO45171 56 years, male, NA, stage:3, alive, 600 days 459.3
DO48693 71 years, male, NA, stage:2, alive, 900 days 452.3
DO23538 67 years, male, NA, stage:2, alive, 450 days 451.8
DO45227 57 years, female, NA, stage:2, alive, 1020 days 450.7
DO50802 49 years, male, NA, stage:2, alive, 930 days 420.4
DO23518 67 years, male, NA, stage:2, alive, 1320 days 414.8
DO45255 81 years, male, NA, stage:3, alive, 720 days 412.6
DO48719 80 years, male, NA, stage:2, alive, 690 days 408.7
DO45107 63 years, female, NA, stage:2, alive, 1710 days 401.9
DO45099 46 years, male, NA, stage:3, alive, 1590 days 398.0
DO48704 68 years, female, NA, stage:3, alive, 750 days 395.9
DO50832 73 years, male, NA, stage:3, alive, 90 days 395.6
DO50809 56 years, male, NA, stage:3, dead, 720 days 394.7
DO23540 73 years, male, NA, stage:1, alive, 750 days 391.6
DO45101 63 years, male, NA, stage:2, alive, 1680 days 387.4
DO48759 73 years, male, NA, stage:3, alive, 720 days 382.8
DO45095 66 years, male, NA, stage:2, alive, 1620 days 382.3
DO45133 64 years, male, NA, stage:3, dead, 660 days 376.8
DO45167 67 years, male, NA, stage:2, dead, 1440 days 376.8
DO23546 63 years, male, NA, stage:2, alive, 1050 days 375.5
DO50859 77 years, male, NA, stage:2, alive, 180 days 374.5
DO45143 69 years, male, NA, stage:3, alive, 1290 days 369.5
DO45177 81 years, female, NA, stage:3, alive, 1260 days 369.5
DO45207 68 years, male, NA, stage:1, alive, 1050 days 366.4
DO227643 79 years, male, NA, stage:2, alive, 1260 days 365.6
DO23533 61 years, male, NA, stage:2, alive, 900 days 362.5
DO45123 78 years, female, NA, stage:2, dead, 570 days 352.7
DO45261 74 years, male, NA, stage:3, alive, 990 days 352.4
DO50787 63 years, male, NA, stage:3, alive, 480 days 352.2
DO45125 58 years, male, NA, stage:3, alive, 1680 days 349.9
DO50793 76 years, male, NA, stage:4, alive, 540 days 345.7
DO50814 83 years, male, NA, stage:3, alive, 420 days 344.9
DO45159 65 years, male, NA, stage:3, alive, 1470 days 341.8
DO45163 76 years, male, NA, stage:2, alive, 960 days 341.7
DO45137 38 years, male, NA, stage:1, alive, 1320 days 338.8
DO45223 67 years, male, NA, stage:4, alive, 1020 days 331.2
DO50850 74 years, male, NA, stage:3, alive, 720 days 322.4
DO45096 69 years, male, NA, stage:2, dead, 1290 days 319.4
DO48751 68 years, male, NA, stage:2, dead, 480 days 316.0
DO50776 75 years, male, NA, stage:1, alive, 690 days 312.1
DO48727 81 years, female, NA, stage:2, dead, 390 days 308.7
DO23516 69 years, male, NA, stage:3, dead, 20 days 306.5
DO45169 74 years, male, NA, stage:3, alive, 1350 days 301.8
DO23510 80 years, female, NA, stage:2, alive, 870 days 297.6
DO23536 56 years, male, NA, stage:2, alive, 930 days 296.1
DO45267 73 years, male, NA, stage:3, dead, 570 days 289.8
DO45229 74 years, male, NA, stage:1, alive, 990 days 284.7
DO45197 51 years, male, NA, stage:2, alive, 1170 days 281.9
DO50816 63 years, male, NA, stage:2, alive, 390 days 275.1
DO45201 49 years, male, NA, stage:1, alive, 900 days 271.0
DO23542 66 years, male, NA, stage:3, alive, 960 days 270.0
DO48742 76 years, male, NA, stage:2, alive, 600 days 265.5
DO48760 70 years, female, NA, stage:2, alive, 690 days 259.5
DO23511 83 years, female, NA, stage:3, dead, 180 days 257.4
DO227801 77 years, female, NA, stage:1, alive, 660 days 253.7
DO50813 56 years, male, NA, stage:2, alive, 420 days 253.2
DO23525 71 years, male, NA, stage:4, alive, 1050 days 251.4
DO48679 72 years, male, NA, stage:2, alive, 1200 days 244.3
DO50825 70 years, male, NA, stage:2, alive, 390 days 243.0
DO45281 83 years, male, NA, stage:4, alive, 750 days 242.1
DO45233 83 years, male, NA, stage:3, alive, 900 days 241.2
DO48733 72 years, male, NA, stage:2, alive, 600 days 240.0
DO50840 49 years, male, NA, stage:2, alive, 330 days 239.4
DO45155 69 years, male, NA, stage:2, alive, 2160 days 238.7
DO23535 67 years, male, NA, stage:1, alive, 960 days 238.7
DO45157 62 years, male, NA, stage:2, alive, 1980 days 237.4
DO48721 58 years, female, NA, stage:1, alive, 900 days 234.5
DO50805 72 years, male, NA, stage:2, alive, 690 days 233.7
DO48732 73 years, male, NA, stage:3, alive, 630 days 229.0
DO45241 49 years, male, NA, stage:1, alive, 1080 days 228.6
DO23544 67 years, male, NA, stage:2, alive, 960 days 224.4
DO45215 65 years, male, NA, stage:2, alive, 1170 days 222.6
DO23550 69 years, male, NA, stage:1, alive, 990 days 221.3
DO23529 72 years, male, NA, stage:4, alive, 930 days 220.4
DO23532 71 years, female, NA, stage:1, alive, 960 days 217.3
DO45165 75 years, male, NA, stage:2, alive, 690 days 215.8
DO45121 61 years, male, NA, stage:3, alive, 1530 days 213.2
DO45103 47 years, male, NA, stage:3, alive, 450 days 211.5
DO48757 68 years, female, NA, stage:3, alive, 480 days 211.4
DO48674 80 years, male, NA, stage:2, alive, 1260 days 211.2
DO23514 64 years, male, NA, stage:2, alive, 1290 days 206.2
DO48701 78 years, male, NA, stage:2, alive, 780 days 206.1
DO45181 84 years, female, NA, stage:2, alive, 1200 days 205.6
DO50857 72 years, male, NA, stage:2, alive, 210 days 201.7
DO50800 74 years, male, NA, stage:2, alive, 510 days 201.0
DO45175 74 years, male, NA, stage:2, alive, 1140 days 200.9
DO45173 63 years, male, NA, stage:3, alive, 1170 days 199.3
DO50822 66 years, male, NA, stage:2, alive, 510 days 195.5
DO48706 72 years, male, NA, stage:2, alive, 870 days 195.5
DO45179 78 years, female, NA, stage:2, alive, 600 days 194.2
DO23509 60 years, male, NA, stage:3, dead, 780 days 190.6
DO48761 55 years, male, NA, stage:2, alive, 870 days 182.2
DO23531 78 years, female, NA, stage:3, alive, 900 days 181.9
DO48723 73 years, male, NA, stage:1, alive, 600 days 179.7
DO23549 74 years, male, NA, stage:3, alive, 990 days 177.8
DO23528 45 years, female, NA, stage:2, alive, 1020 days 176.5
DO50818 65 years, male, NA, stage:2, alive, 510 days 175.9
DO48672 81 years, male, NA, stage:2, alive, 450 days 170.0
DO23541 65 years, male, NA, stage:2, alive, 930 days 169.9
DO48743 69 years, female, NA, stage:2, alive, 570 days 169.6
DO23517 62 years, male, NA, stage:2, alive, 1200 days 168.7
DO45195 62 years, male, NA, stage:1, alive, 390 days 167.3
DO50798 77 years, male, NA, stage:3, dead, 30 days 156.0
DO48725 66 years, male, NA, stage:1, alive, 780 days 156.0
DO45263 67 years, male, NA, stage:3, dead, 270 days 153.1
DO50789 73 years, female, NA, stage:2, alive, 570 days 152.7
DO45141 73 years, male, NA, stage:2, alive, 1320 days 149.7
DO45149 70 years, female, NA, stage:2, alive, 1260 days 146.9
DO45243 74 years, female, NA, stage:3, alive, 930 days 146.2
DO50803 62 years, female, NA, stage:1, alive, 540 days 146.2
DO23526 66 years, male, NA, stage:3, alive, 1050 days 146.0
DO45153 77 years, female, NA, stage:2, alive, 1380 days 146.0
DO23551 73 years, male, NA, stage:3, dead, 150 days 144.7
DO45091 56 years, male, NA, stage:2, dead, 1320 days 142.3
DO48697 64 years, female, NA, stage:2, dead, 810 days 142.1
DO45221 75 years, female, NA, stage:4, dead, 390 days 141.0
DO45253 50 years, male, NA, stage:2, alive, 870 days 137.5
DO50791 79 years, female, NA, stage:1, dead, 480 days 136.6
DO45113 58 years, male, NA, stage:3, alive, 1560 days 136.0
DO45205 67 years, female, NA, stage:2, dead, 90 days 134.5
DO48700 78 years, female, NA, stage:2, alive, 810 days 130.9
DO45131 53 years, male, NA, stage:4, dead, 360 days 123.7
DO50799 66 years, female, NA, stage:2, alive, 540 days 121.2
DO23545 67 years, male, NA, stage:2, dead, 570 days 120.6
DO45092 62 years, male, NA, stage:4, dead, 1200 days 118.1
DO45269 59 years, male, NA, stage:3, alive, 750 days 117.8
DO45225 69 years, male, NA, stage:1, alive, 1050 days 116.9
DO50819 72 years, female, NA, stage:2, alive, 510 days 112.5
DO23547 74 years, male, NA, stage:1, alive, 1020 days 111.7
DO45117 73 years, female, NA, stage:2, dead, 1110 days 110.9
DO48712 50 years, male, NA, stage:2, alive, 810 days 107.9
DO45235 68 years, female, NA, stage:1, alive, 900 days 104.8
DO48741 64 years, male, NA, stage:3, alive, 240 days 104.3
DO50844 75 years, male, NA, stage:4, alive, 300 days 103.2
DO45273 62 years, male, NA, stage:2, alive, 480 days 102.0
DO45135 77 years, male, NA, stage:1, alive, 1410 days 99.9
DO45109 63 years, male, NA, stage:2, alive, 1590 days 99.4
DO45203 71 years, female, NA, stage:2, alive, 1170 days 97.0
DO45093 71 years, male, NA, stage:2, dead, 720 days 96.5
DO45231 84 years, male, NA, stage:2, alive, 930 days 94.8
DO50774 68 years, female, NA, stage:2, alive, 720 days 94.5
DO45105 61 years, male, NA, stage:1, alive, 1680 days 93.5
DO48716 71 years, male, NA, stage:2, alive, 720 days 88.5
DO23552 80 years, female, NA, stage:1, alive, 810 days 86.8
DO45119 74 years, male, NA, stage:3, dead, 510 days 85.9
DO45199 86 years, female, NA, stage:2, alive, 1350 days 85.5
DO45257 46 years, male, NA, stage:3, alive, 810 days 83.6
DO45297 61 years, female, NA, stage:4, dead, 1260 days 81.3
DO48682 72 years, female, NA, stage:3, dead, 120 days 79.4
DO48737 52 years, male, NA, stage:1, alive, 720 days 77.1
DO23519 65 years, male, NA, stage:3, alive, 630 days 70.7
DO23530 53 years, male, NA, stage:4, dead, 180 days 68.3
DO45219 78 years, male, NA, stage:2, alive, 1080 days 66.4
DO48717 54 years, male, NA, stage:4, dead, 180 days 65.2
DO48736 76 years, female, NA, stage:1, alive, 600 days 64.5
DO45115 81 years, male, NA, stage:2, alive, 840 days 61.6
DO45211 76 years, male, NA, stage:3, alive, 240 days 61.5
DO45213 58 years, male, NA, stage:1, alive, 1200 days 58.6
DO23508 79 years, female, NA, stage:2, alive, 390 days 58.0
DO45139 63 years, male, NA, stage:3, alive, 1320 days 58.0
DO50820 77 years, female, NA, stage:3, alive, 510 days 56.9
DO45305 66 years, male, NA, stage:4, alive, 300 days 52.4
DO50806 70 years, male, NA, stage:4, alive, 540 days 49.8
DO45249 57 years, male, NA, stage:1, alive, 630 days 48.1
DO45161 74 years, male, NA, stage:2, dead, 540 days 46.0
DO48715 58 years, female, NA, stage:2, dead, 690 days 44.1
DO45239 42 years, male, NA, stage:2, alive, 870 days 43.6
DO45237 58 years, male, NA, stage:2, alive, 900 days 42.9
DO45303 62 years, female, NA, stage:3, alive, 990 days 42.0
DO50785 37 years, male, NA, stage:4, dead, 90 days 41.1
DO48681 57 years, male, NA, stage:2, alive, 900 days 39.4
DO50855 47 years, male, NA, stage:2, alive, 570 days 38.0
DO45287 74 years, male, NA, stage:1, alive, 390 days 37.9
DO50845 72 years, male, NA, stage:3, alive, 210 days 37.3
DO45191 61 years, female, NA, stage:2, alive, 1200 days 34.0
DO23521 63 years, male, NA, stage:3, alive, 1110 days 33.6
DO45247 31 years, female, NA, stage:2, alive, 210 days 33.0
DO45183 72 years, female, NA, stage:2, dead, 570 days 32.5
DO45185 89 years, male, NA, stage:2, alive, 600 days 32.2
DO45251 57 years, female, NA, stage:2, alive, 900 days 31.4
DO23524 71 years, female, NA, stage:2, alive, 1050 days 30.6
DO45187 32 years, female, NA, stage:1, alive, 1260 days 30.1
DO45301 56 years, male, NA, stage:2, dead, 1440 days 29.6
DO45279 67 years, male, NA, stage:3, alive, 1290 days 28.3
DO45275 65 years, male, NA, stage:3, dead, 10 days 27.5
DO50829 78 years, male, NA, stage:3, alive, 570 days 27.4
DO23537 79 years, male, NA, stage:2, dead, 900 days 21.3
DO48728 74 years, female, NA, stage:2, alive, 150 days 21.1
DO23515 71 years, male, NA, stage:2, alive, 1230 days 20.2
DO45217 69 years, female, NA, stage:3, dead, 270 days 20.1
DO45285 59 years, male, NA, stage:3, alive, 480 days 20.1
DO50778 60 years, male, NA, stage:4, alive, 630 days 18.1
DO45189 85 years, female, NA, stage:2, alive, 1200 days 17.9
DO48730 73 years, female, NA, stage:2, alive, 630 days 16.7
DO45277 64 years, male, NA, stage:3, alive, 600 days 16.2
DO45283 60 years, male, NA, stage:3, alive, 510 days 15.7
DO45289 78 years, female, NA, stage:3, alive, 360 days 15.6
DO45145 78 years, male, NA, stage:3, dead, 60 days 15.6
DO48720 62 years, female, NA, stage:2, alive, 570 days 15.6
DO23523 52 years, male, NA, stage:3, alive, 1080 days 15.3
DO45307 54 years, female, NA, stage:4, dead, 240 days 12.9
DO48747 62 years, male, NA, stage:3, alive, 540 days 12.3
DO45209 70 years, male, NA, stage:4, alive, 1350 days 10.9
DO45127 73 years, male, NA, stage:3, dead, 420 days 10.1
DO45265 73 years, male, NA, stage:3, alive, 1020 days 8.9
DO45245 75 years, female, NA, stage:2, dead, 240 days 8.5
DO45259 65 years, male, NA, stage:3, alive, 330 days 8.4
DO50815 62 years, male, NA, stage:3, alive, 150 days 4.2
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
1027 Tumor 1.4
857 Tumor 1.4
445 Tumor 1.3
741 Tumor 1.1
911 Tumor 1.0
171 Tumor 1.0
863 Tumor 1.0
481 Tumor 0.9
128 Normal 0.9
648 Normal 0.8
977 Tumor 0.8
878 Normal 0.8
342 Normal 0.8
452 Normal 0.7
132 Normal 0.7
627 Tumor 0.7
186 Normal 0.7
314 Normal 0.7
466 Normal 0.7
354 Normal 0.7
147 Tumor 0.7
426 Normal 0.7
422 Normal 0.6
232 Normal 0.6
196 Normal 0.6
124 Normal 0.6
332 Normal 0.6
388 Normal 0.6
616 Normal 0.6
662 Normal 0.6
636 Normal 0.6
572 Normal 0.6
376 Normal 0.6
231 Tumor 0.6
268 Normal 0.6
615 Tumor 0.6
1045 Tumor 0.6
278 Normal 0.6
744 Normal 0.6
358 Normal 0.6
172 Normal 0.6
365 Tumor 0.6
564 Normal 0.6
261 Tumor 0.5
384 Normal 0.5
882 Normal 0.5
618 Normal 0.5
424 Normal 0.5
148 Normal 0.5
368 Normal 0.5
742 Normal 0.5
123 Tumor 0.5
938 Normal 0.5
414 Normal 0.5
862 Normal 0.5
864 Normal 0.5
162 Normal 0.5
427 Tumor 0.5
356 Normal 0.5
494 Normal 0.4
628 Normal 0.4
568 Normal 0.4
534 Normal 0.4
464 Normal 0.4
222 Normal 0.4
366 Normal 0.4
146 Normal 0.4
746 Normal 0.4
868 Normal 0.4
866 Normal 0.4
298 Normal 0.4
818 Normal 0.4
362 Normal 0.4
884 Normal 0.4
446 Normal 0.4
698 Normal 0.4
436 Normal 0.4
816 Normal 0.4
1015 Tumor 0.4
722 Normal 0.4
428 Normal 0.4
114 Normal 0.4
738 Normal 0.4
262 Normal 0.4
142 Normal 0.4
138 Normal 0.4
312 Normal 0.4
412 Normal 0.4
513 Tumor 0.4
136 Normal 0.4
258 Normal 0.4
824 Normal 0.4
493 Tumor 0.4
111 Normal 0.3
423 Tumor 0.3
477 Tumor 0.3
214 Normal 0.3
392 Normal 0.3
394 Normal 0.3
664 Normal 0.3
858 Normal 0.3
468 Normal 0.3
1046 Normal 0.3
284 Normal 0.3
557 Tumor 0.3
852 Normal 0.3
912 Normal 0.3
922 Normal 0.3
482 Normal 0.3
462 Normal 0.3
538 Normal 0.3
224 Normal 0.3
954 Normal 0.3
914 Normal 0.3
642 Normal 0.3
432 Normal 0.3
433 Tumor 0.3
714 Normal 0.3
267 Tumor 0.3
488 Normal 0.2
546 Normal 0.2
723 Tumor 0.2
1022 Normal 0.2
465 Tumor 0.2
286 Normal 0.2
786 Normal 0.2
672 Normal 0.2
444 Normal 0.2
1014 Normal 0.2
861 Tumor 0.2
228 Normal 0.2
982 Normal 0.2
1032 Normal 0.2
484 Normal 0.2
956 Normal 0.2
944 Normal 0.2
574 Normal 0.2
913 Tumor 0.2
478 Normal 0.2
352 Normal 0.2
728 Normal 0.2
955 Tumor 0.2
188 Normal 0.2
666 Normal 0.1
867 Tumor 0.1
126 Normal 0.1
364 Normal 0.1
558 Normal 0.1
1028 Normal 0.1
968 Normal 0.1
514 Normal 0.1
1016 Normal 0.1
1026 Normal 0.1
874 Normal 0.1
984 Normal 0.1
716 Normal 0.1
434 Normal 0.1
756 Normal 0.1
526 Normal 0.1
951 Tumor 0.1
976 Normal 0.1
456 Normal 0.1
685 Tumor 0.1
778 Normal 0.1
1044 Normal 0.1
448 Normal 0.1
472 Normal 0.1
396 Normal 0.1
328 Normal 0.1
777 Tumor 0.1
416 Normal 0.1
145 Tumor 0.1
353 Tumor 0.1
918 Normal 0.0
212 Normal 0.0
344 Normal 0.0
518 Normal 0.0
528 Normal 0.0
375 Tumor 0.0
755 Tumor 0.0
474 Normal 0.0
926 Normal 0.0
958 Normal 0.0
873 Tumor 0.0
272 Normal 0.0
395 Tumor 0.0
554 Normal 0.0
1042 Normal 0.0
361 Tumor -0.1
516 Normal -0.1
641 Tumor -0.1
112 Tumor -0.1
686 Normal -0.1
696 Normal -0.1
964 Normal -0.1
921 Tumor -0.1
191 Tumor -0.1
415 Tumor -0.1
386 Normal -0.1
635 Tumor -0.1
327 Tumor -0.1
978 Normal -0.1
883 Tumor -0.1
727 Tumor -0.1
498 Normal -0.2
785 Tumor -0.2
916 Normal -0.2
721 Tumor -0.2
966 Normal -0.2
383 Tumor -0.2
1041 Tumor -0.2
451 Tumor -0.2
192 Normal -0.2
915 Tumor -0.2
218 Normal -0.2
195 Tumor -0.2
952 Normal -0.2
924 Normal -0.2
492 Normal -0.2
524 Normal -0.3
137 Tumor -0.3
185 Tumor -0.3
435 Tumor -0.3
865 Tumor -0.3
483 Tumor -0.3
113 Tumor -0.3
563 Tumor -0.3
127 Tumor -0.3
411 Tumor -0.4
357 Tumor -0.4
1013 Tumor -0.4
567 Tumor -0.4
963 Tumor -0.4
647 Tumor -0.4
421 Tumor -0.4
881 Tumor -0.4
814 Normal -0.4
981 Tumor -0.4
663 Tumor -0.4
313 Tumor -0.5
161 Tumor -0.5
461 Tumor -0.5
277 Tumor -0.5
943 Tumor -0.5
571 Tumor -0.5
953 Tumor -0.5
187 Tumor -0.5
536 Normal -0.5
431 Tumor -0.6
221 Tumor -0.6
141 Tumor -0.6
553 Tumor -0.6
937 Tumor -0.6
447 Tumor -0.6
341 Tumor -0.6
724 Normal -0.6
227 Tumor -0.6
515 Tumor -0.6
217 Tumor -0.6
813 Tumor -0.6
257 Tumor -0.6
443 Tumor -0.7
135 Tumor -0.7
527 Tumor -0.7
975 Tumor -0.7
917 Tumor -0.8
851 Tumor -0.8
471 Tumor -0.8
413 Tumor -0.8
617 Tumor -0.8
213 Tumor -0.8
737 Tumor -0.8
925 Tumor -0.8
823 Tumor -0.8
715 Tumor -0.9
713 Tumor -0.9
271 Tumor -0.9
455 Tumor -0.9
745 Tumor -0.9
1021 Tumor -0.9
1043 Tumor -1.0
393 Tumor -1.0
297 Tumor -1.0
533 Tumor -1.1
525 Tumor -1.1
697 Tumor -1.1
467 Tumor -1.1
125 Tumor -1.1
491 Tumor -1.1
473 Tumor -1.2
877 Tumor -1.2
387 Tumor -1.3
311 Tumor -1.3
425 Tumor -1.3
817 Tumor -1.3
665 Tumor -1.4
695 Tumor -1.4
517 Tumor -1.4
223 Tumor -1.5
355 Tumor -1.5
363 Tumor -1.5
463 Tumor -1.6
331 Tumor -1.6
391 Tumor -1.6
343 Tumor -1.6
923 Tumor -1.6
573 Tumor -1.6
367 Tumor -1.6
497 Tumor -1.6
1031 Tumor -1.7
351 Tumor -1.7
671 Tumor -1.7
487 Tumor -1.8
131 Tumor -1.8
983 Tumor -1.8
957 Tumor -1.8
523 Tumor -1.8
1025 Tumor -1.8
815 Tumor -1.8
743 Tumor -1.9
967 Tumor -1.9
545 Tumor -2.0
537 Tumor -2.1
661 Tumor -2.2
283 Tumor -2.2
211 Tumor -2.2
965 Tumor -2.3
285 Tumor -2.3
385 Tumor -2.3
535 Tumor -2.4
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA018897

Antibody HPA074629
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Carcinoma, Hepatocellular, NOS
Cholangiocarcinoma

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org